SUBSTANCES THAT CAN TRIGGER ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT HAVE ANTI-MELANOMA ACTIVITY IN MICE

被引：9

作者：

COOPER, PD

SIM, RB

机构：

[1] UNIV OXFORD,SIR WILLIAM DUNN SCH PATHOL,OXFORD OX1 3RE,ENGLAND

[2] UNIV OXFORD,DEPT BIOCHEM,MRC,IMMUNOCHEM UNIT,OXFORD OX1 3QU,ENGLAND

来源：

INTERNATIONAL JOURNAL OF CANCER | 1984年 / 33卷 / 05期

关键词：

D O I：

10.1002/ijc.2910330520

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：683 / 687

页数：5

共 34 条

[1]

BRADE V, 1976, IMMUNOLOGY, V30, P171

[2] PROTEIN-A TREATMENT OF CANCER - ACTIVATION OF A SERUM COMPONENT WITH TRANS-SPECIES ANTI-B16 MELANOMA ACTIVITY [J].

COOPER, PD ;

MASINELLO, GR .

INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (06) :737-744

[3] COMPLEMENT AND LEUKOCYTE-MEDIATED PULMONARY DYSFUNCTION IN HEMODIALYSIS [J].

CRADDOCK, PR ;

FEHR, J ;

BRIGHAM, KL ;

KRONENBERG, RS ;

JACOB, HS .

NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (14) :769-774

[4] THE BINDING OF COMPLEMENT COMPONENT-C3 TO ANTIBODY-ANTIGEN AGGREGATES AFTER ACTIVATION OF THE ALTERNATIVE PATHWAY IN HUMAN-SERUM [J].

GADD, KJ ;

REID, KBM .

BIOCHEMICAL JOURNAL, 1981, 195 (02) :471-480

[5]

GORDON BR, 1983, J NATL CANCER I, V70, P1127

[6]

HAKANSSON L, 1983, EUROP SOC CLIN INV A, V39

[7]

KINET JP, 1982, EUR J CLIN INVEST, V12, P19

[8]

LACHMANN PJ, 1979, ANTIGENS, V5, P283

[9]

LAW SK, 1980, J IMMUNOL, V125, P634

[10]

MACKINTOSH FR, 1983, AM SOC CLIN ONC ABST, P54

← 1 2 3 4 →